• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T和NK淋巴细胞白血病/淋巴瘤:2023年SH/EAHP研讨会报告

T and NK lymphoblastic leukemia/lymphoma: Report from the 2023 SH/EAHP Workshop.

作者信息

Weinberg Olga K, Bueso-Ramos Carlos E, Kanagal-Shamanna Rashmi

机构信息

Department of Hematopathology, The University of Texas Southwestern Medical Center, Dallas, TX, United States.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

出版信息

Am J Clin Pathol. 2025 Jul 11;164(1):26-35. doi: 10.1093/ajcp/aqaf015.

DOI:10.1093/ajcp/aqaf015
PMID:40646675
Abstract

OBJECTIVES

The 2023 Society for Hematopathology/European Association for Hematopathology Workshop addressed advancements in the diagnosis and classification of T- and natural killer (NK)-cell lymphomas/leukemias.

METHODS

Session 8 of the workshop collected a diverse set of 38 cases of immature T- and NK-cell lymphoma/leukemias, as well as acute leukemia of ambiguous lineage (ALAL) and other miscellaneous cases, including indolent T-lymphoblastic proliferations.

RESULTS

Twenty patients with T-lymphoblastic leukemia/lymphoma (T-LBL/L) and 3 patients with early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) presented at a median age of 21.5 years. Male sex was predominant (70% of all cases), with 40% having a mediastinal mass. Cases (60%) were negative for both CD34 and TdT. In addition, 7 ALAL and 3 mixed phenotype acute leukemia, T/myeloid subtypes were submitted with a median presenting age of 16 (range, 11-56) years, and most patients (67%) frequently showed adenopathy or splenomegaly. A single case of NK acute lymphoblastic leukemia was also submitted.

CONCLUSIONS

This session highlighted unusual T-LBL/L cases with expression of cytotoxic markers, γ/δ phenotype, a more mature immunophenotype, and ALAL that are challenging to classify. Among T-ALL cases, interesting relapse changes were identified, with 1 patient developing a mature NK-cell phenotype. Patients with ALAL presented in an unusual setting of prior therapy or a germline mutation.

摘要

目的

2023年血液病理学学会/欧洲血液病理学协会研讨会探讨了T细胞和自然杀伤(NK)细胞淋巴瘤/白血病诊断与分类的进展。

方法

研讨会第8场会议收集了38例不同类型的未成熟T细胞和NK细胞淋巴瘤/白血病病例,以及谱系不明的急性白血病(ALAL)和其他杂项病例,包括惰性T淋巴细胞增殖病例。

结果

20例T淋巴细胞白血病/淋巴瘤(T-LBL/L)患者和3例早期T细胞前体急性淋巴细胞白血病(ETP-ALL)患者,中位年龄为21.5岁。男性占主导(占所有病例的70%),40%有纵隔肿块。60%的病例CD34和TdT均为阴性。此外,提交了7例ALAL和3例混合表型急性白血病(T/髓系亚型),中位发病年龄为16岁(范围11 - 56岁),大多数患者(67%)常有淋巴结肿大或脾肿大。还提交了1例NK急性淋巴细胞白血病病例。

结论

本次会议强调了具有细胞毒性标志物表达、γ/δ表型、更成熟免疫表型的不寻常T-LBL/L病例以及难以分类的ALAL。在T-ALL病例中,发现了有趣的复发变化,1例患者发展为成熟NK细胞表型。ALAL患者出现在先前治疗或种系突变的不寻常情况下。

相似文献

1
T and NK lymphoblastic leukemia/lymphoma: Report from the 2023 SH/EAHP Workshop.T和NK淋巴细胞白血病/淋巴瘤:2023年SH/EAHP研讨会报告
Am J Clin Pathol. 2025 Jul 11;164(1):26-35. doi: 10.1093/ajcp/aqaf015.
2
Genomics of T-lymphoblastic leukemia/lymphoma: 2023 SH/EAHP workshop proceedings.T淋巴细胞母细胞白血病/淋巴瘤的基因组学:2023年SH/EAHP研讨会会议记录
Am J Clin Pathol. 2025 Jul 11;164(1):76-84. doi: 10.1093/ajcp/aqaf035.
3
Blood- and bone marrow-based mature T-cell and natural killer cell leukemias and lymphomas: a summary in the series of the 2023 SH/EAHP Workshop.基于血液和骨髓的成熟T细胞及自然杀伤细胞白血病和淋巴瘤:2023年SH/EAHP研讨会系列总结
Am J Clin Pathol. 2025 Jul 11;164(1):7-25. doi: 10.1093/ajcp/aqaf009.
4
Epstein-Barr virus-positive T- and NK-cell lymphoproliferative disorders: Report from the 2023 SH/EA4HP Lymphoma Workshop.爱泼斯坦-巴尔病毒阳性T细胞和NK细胞淋巴增殖性疾病:2023年SH/EA4HP淋巴瘤研讨会报告
Am J Clin Pathol. 2025 Jul 11;164(1):46-64. doi: 10.1093/ajcp/aqaf020.
5
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.针对儿童癌症治疗期间及治疗后的儿童和青少年的体育锻炼训练干预措施。
Cochrane Database Syst Rev. 2016 Mar 31;3(3):CD008796. doi: 10.1002/14651858.CD008796.pub3.
6
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.
7
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.针对儿童癌症治疗期间及治疗后的儿童和青少年的体育锻炼训练干预措施。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD008796. doi: 10.1002/14651858.CD008796.pub2.
8
Noncutaneous cytotoxic T-cell lymphomas: Recent advances and emerging concepts: A report of the 2023 Society of Hematopathology/European Association for Haematopathology T-cell lymphoma workshop.非皮肤细胞毒性T细胞淋巴瘤:最新进展与新兴概念:2023年血液病理学学会/欧洲血液病理学协会T细胞淋巴瘤研讨会报告
Am J Clin Pathol. 2025 Jul 11;164(1):36-45. doi: 10.1093/ajcp/aqaf016.
9
Post-transplant relapse in pediatric acute lymphoblastic leukemia in the era of CAR-T cell therapy. A multicenter analysis of Grupo Español de Trasplante Hematopoyetico y Terapia Celular (GETH-TC) Pediatric Committee.嵌合抗原受体T细胞(CAR-T)疗法时代小儿急性淋巴细胞白血病的移植后复发。西班牙血液移植与细胞治疗协作组(GETH-TC)儿科委员会的多中心分析
Cytotherapy. 2025 Apr;27(4):438-445. doi: 10.1016/j.jcyt.2024.11.016. Epub 2024 Dec 2.
10
Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Nonrandomized Clinical Trial.达沙替尼与嵌合抗原受体T细胞疗法治疗新诊断的费城染色体阳性急性淋巴细胞白血病:一项非随机临床试验
JAMA Oncol. 2025 Apr 17. doi: 10.1001/jamaoncol.2025.0674.